Cannabis Pharmaceuticals Business Research Report 2026: An $111.1 Billion Market by 2032 from $4.7 Billion in 2025 Featuring AbbVie, Aphria, Aurora Cannabis, Bausch Health, and Canopy Growth
The cannabis pharmaceuticals market is poised for significant growth due to rising medical cannabis legalization, increasing R&D investment, and demand for alternative treatments. Key opportunities include advancements in cannabinoid research, therapeutic app…
Dublin, May 18, 2026 (GLOBE NEWSWIRE) — The “Cannabis Pharmaceuticals – Global Strategic Business Report” has been added to ResearchAndMarkets.com’s offering.
The global market for Cannabis Pharmac…